Dengue Fever in the Philippines
One of Southeast Asia's highest-burden dengue countries, with annual outbreaks affecting all 17 regions and the lasting impact of the Dengvaxia controversy.
Key Facts
| Metric | Data |
| Annual cases | 70,000–200,000+ |
| Annual deaths | 300–1,000 |
| Peak season | July–October (southwest monsoon) |
| Serotypes | All 4 (DENV 1–4) |
| Health authority | Department of Health (DOH Philippines) |
The Dengvaxia Controversy
In 2016–2017, the Philippine government launched a school-based mass vaccination program with Dengvaxia (Sanofi), vaccinating over 800,000 children without first testing whether they had prior dengue infection. In late 2017, Sanofi revealed that Dengvaxia increases risk of severe dengue in people who were dengue-naïve at vaccination — the antibodies it generates can cause ADE upon first natural infection.
The fallout was severe: the program was stopped, criminal charges were filed, and vaccine hesitancy in the Philippines spiked dramatically — affecting uptake of COVID-19 and other routine vaccines years later. The incident is a global case study in the dangers of insufficient pre-deployment screening and the lasting damage a vaccine safety event can cause to public trust.
Prevention
- DEET repellent, long clothing during daylight hours
- Remove standing water (key in archipelago environments with water storage)
- Use screens and air conditioning
- Community clean-up days (Oplan Linis)
- Seek medical care for any fever — ask for NS1 test
Get Dengue Outbreak Alerts
Frequently Asked Questions
Over 800,000 Filipino school children were vaccinated with Dengvaxia without prior testing. Dengvaxia can cause severe dengue in dengue-naive individuals on subsequent natural infection. The program was halted after this risk emerged, causing lasting vaccine hesitancy nationwide.
Peak season is July–October during the southwest monsoon. The Philippines sees dengue year-round but cases are lowest during the drier months of January–April.
Sources: Philippines DOH; WHO WPRO; Lancet analysis of Dengvaxia controversy; PAHO dengue data.
Related: Dengue overview · India dengue · Brazil dengue